Arbutus Biopharma Corp (NASDAQ:ABUS)

8.80
Delayed Data
As of Aug 20
 -0.30 / -3.30%
Today’s Change
3.45
Today|||52-Week Range
12.60
+74.26%
Year-to-Date
No recent news for Arbutus Biopharma Corp.

Today’s Trading

Previous close9.10
Today’s open9.05
Day’s range8.65 - 9.10
Volume144,381
Average volume (3 months)389,768
Market cap$490.3M
Data as of 4:00pm ET, 08/20/2018

Growth & Valuation

Earnings growth (last year)+78.45%
Earnings growth (this year)+23.40%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+617.64%
P/E ratioNM
Price/Sales25.83
Price/Book3.67

Competitors

 Today’s
change
Today’s
% change
ARDXArdelyx Inc+0.15+3.80%
DRRXDURECT Corp-0.04-3.05%
CPRXCatalyst Pharmaceuti...-0.09-3.10%
PETXAratana Therapeutics...+0.04+0.79%
Data as of 4:00pm ET, 08/20/2018

Financials

Next reporting dateNovember 8, 2018
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$10.7M
Annual profit (last year)-$84.4M
Net profit margin-788.91%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Financial Officer
David C. Hastings
Corporate headquarters
Burnaby, British Columbia

Forecasts